This week we loved talking with Dr Kylie Quinn, who is a Vice-Chancellor’s Research Fellow and leads the Ageing and Immunotherapies Group at RMIT University. Her group is developing ways to improve immune responses in older people during vaccination and new cell-based cancer therapies. Immune cells from older people become more difficult to activate, so her team are identifying factors that limit activation with the aim of targeting these factors to improve immune health.

Kylie has received a number of awards for her work on ageing and immunity, including the John and Eileen Haddon Award in 2019 and a Weary Dunlop Award in 2022. More broadly, Kylie has a long-standing interest in issues of equity in science, volunteering with several diversity and inclusion-focused groups. She is also a keen communicator of science and was a key figure communicating on how vaccines work and are developed to the Australian public during the COVID-19 pandemic.

You call follow Kylie and find out more about her work here:

https://twitter.com/DrQuinn4realz

Transcript: https://go.unimelb.edu.au/v9te